Alumis Balance Sheet
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alumis financial position
At the end of fiscal 2025, Alumis reported total assets of $411.9 million, up 20.8% from a year earlier against total liabilities of $110.6 million. Shareholders' equity stood at $301.3 million, or 73.1% of assets. The company held $89.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.34, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Alumis balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 89.67M | 169.53M | 46.00M |
| Short-Term Investments | 218.83M | 118.74M | 2.96M |
| Total Current Assets | 318.23M | 306.19M | 53.36M |
| Property, Plant & Equipment | 18.19M | 20.97M | 22.44M |
| Total Assets | 411.94M | 340.99M | 89.61M |
| Accounts Payable | 10.11M | 9.62M | 1.12M |
| Total Current Liabilities | 73.32M | 50.91M | 20.87M |
| Total Liabilities | 110.64M | 80.89M | 53.50M |
| Shareholders' Equity | 301.30M | 260.10M | -339.26M |
| Retained Earnings | -901.88M | -658.55M | -364.32M |
| Net Cash (Debt) | 308.50M | 288.26M | 48.95M |
This table shows 3 annual periods of Alumis's balance sheet, from FY 2025 back to FY 2023, across 11 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ALMS's reporting calendar. What is a balance sheet?